Jonathan Welsh

Jonathan Welsh is a seasoned professional in the pharmaceutical industry, currently serving as a Senior Bioanalytical Scientist at Sterling Pharma Solutions since June 2023, leading teams in method development and QC analytics for large molecule drug conjugates. Prior to this role, Jonathan held various positions at Teva Pharmaceuticals from July 2015 to May 2023, culminating as New Product Development Team Leader, where expertise in regulatory guidance and complex formulations was applied to ensure successful product development and submissions. Jonathan's earlier experience includes roles as a Scientist through Principal Scientist at Teva, an Experimental Officer/QC Analyst at Covance, and a Development Analyst at Pharmaserve Northwest Ltd. Jonathan holds a Master’s Degree in Medicinal Chemistry with Pharmacology from the University of Liverpool, obtained in 2011.